

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | hydrogen peroxide catabolic process (GO:0042744) | 9.98732745 |
| 2 | mammary gland epithelial cell differentiation (GO:0060644) | 9.47240528 |
| 3 | primary alcohol catabolic process (GO:0034310) | 9.46133698 |
| 4 | mitochondrial calcium ion transport (GO:0006851) | 8.34452072 |
| 5 | mitochondrion distribution (GO:0048311) | 7.99977697 |
| 6 | ribosome assembly (GO:0042255) | 7.26747248 |
| 7 | behavioral response to pain (GO:0048266) | 6.96584051 |
| 8 | phasic smooth muscle contraction (GO:0014821) | 6.76284258 |
| 9 | Golgi transport vesicle coating (GO:0048200) | 6.27159046 |
| 10 | COPI coating of Golgi vesicle (GO:0048205) | 6.27159046 |
| 11 | skeletal muscle fiber development (GO:0048741) | 6.17947204 |
| 12 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 6.15261265 |
| 13 | response to water (GO:0009415) | 6.08860296 |
| 14 | desmosome organization (GO:0002934) | 5.92549555 |
| 15 | ear development (GO:0043583) | 5.48073836 |
| 16 | hydrogen peroxide metabolic process (GO:0042743) | 5.47930142 |
| 17 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 5.29949202 |
| 18 | signal peptide processing (GO:0006465) | 5.28192588 |
| 19 | myotube cell development (GO:0014904) | 5.25961343 |
| 20 | maternal placenta development (GO:0001893) | 4.92598677 |
| 21 | galactose metabolic process (GO:0006012) | 4.77033138 |
| 22 | nucleoside diphosphate catabolic process (GO:0009134) | 4.64298751 |
| 23 | ethanol oxidation (GO:0006069) | 4.61946880 |
| 24 | valine metabolic process (GO:0006573) | 4.61702267 |
| 25 | aggressive behavior (GO:0002118) | 4.57235123 |
| 26 | purinergic receptor signaling pathway (GO:0035587) | 4.52541363 |
| 27 | response to ATP (GO:0033198) | 4.35718414 |
| 28 | neuromuscular synaptic transmission (GO:0007274) | 4.35546659 |
| 29 | regulation of water loss via skin (GO:0033561) | 4.33450258 |
| 30 | cellular copper ion homeostasis (GO:0006878) | 4.32698676 |
| 31 | proline metabolic process (GO:0006560) | 4.32191322 |
| 32 | diol metabolic process (GO:0034311) | 4.30843424 |
| 33 | negative regulation of cell size (GO:0045792) | 4.23059520 |
| 34 | transcytosis (GO:0045056) | 4.22532590 |
| 35 | endothelial cell chemotaxis (GO:0035767) | 4.20635106 |
| 36 | glycoprotein catabolic process (GO:0006516) | 4.17703777 |
| 37 | short-chain fatty acid metabolic process (GO:0046459) | 4.16906504 |
| 38 | hepatocyte apoptotic process (GO:0097284) | 4.16392010 |
| 39 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 4.11719521 |
| 40 | sensory perception of taste (GO:0050909) | 4.06856145 |
| 41 | glutathione biosynthetic process (GO:0006750) | 4.06074287 |
| 42 | regulation of autophagic vacuole assembly (GO:2000785) | 4.04962475 |
| 43 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 4.04377124 |
| 44 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 4.01319566 |
| 45 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.95956475 |
| 46 | branched-chain amino acid catabolic process (GO:0009083) | 3.95315721 |
| 47 | protein maturation by protein folding (GO:0022417) | 3.95281511 |
| 48 | alpha-linolenic acid metabolic process (GO:0036109) | 3.93821733 |
| 49 | protein retention in ER lumen (GO:0006621) | 3.91120342 |
| 50 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.89277166 |
| 51 | ethanol metabolic process (GO:0006067) | 3.87971334 |
| 52 | positive regulation of nuclease activity (GO:0032075) | 3.81864721 |
| 53 | cardiac right ventricle morphogenesis (GO:0003215) | 3.80495252 |
| 54 | Golgi organization (GO:0007030) | 3.73436196 |
| 55 | COPII vesicle coating (GO:0048208) | 3.72881340 |
| 56 | sphingosine metabolic process (GO:0006670) | 3.72505551 |
| 57 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.72083490 |
| 58 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.69906153 |
| 59 | neuronal action potential (GO:0019228) | 3.64864807 |
| 60 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 3.64459866 |
| 61 | oocyte development (GO:0048599) | 3.64377709 |
| 62 | mitochondrion localization (GO:0051646) | 3.60355592 |
| 63 | branched-chain amino acid metabolic process (GO:0009081) | 3.57965238 |
| 64 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.53818751 |
| 65 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.52105875 |
| 66 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.51655112 |
| 67 | ER-nucleus signaling pathway (GO:0006984) | 3.48591220 |
| 68 | cell differentiation involved in embryonic placenta development (GO:0060706) | 3.47883991 |
| 69 | sphingoid metabolic process (GO:0046519) | 3.47190715 |
| 70 | establishment of skin barrier (GO:0061436) | 3.46569872 |
| 71 | 4-hydroxyproline metabolic process (GO:0019471) | 3.43013834 |
| 72 | regulation of nuclease activity (GO:0032069) | 3.42091146 |
| 73 | neuromuscular junction development (GO:0007528) | 3.41817925 |
| 74 | cellular response to unfolded protein (GO:0034620) | 3.41129176 |
| 75 | response to pain (GO:0048265) | 3.38218114 |
| 76 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.37315317 |
| 77 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.37268706 |
| 78 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.37252673 |
| 79 | mammary gland alveolus development (GO:0060749) | 3.36100025 |
| 80 | regulation of histone H3-K27 methylation (GO:0061085) | 3.32543439 |
| 81 | vesicle coating (GO:0006901) | 3.31732269 |
| 82 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.31373461 |
| 83 | acetyl-CoA metabolic process (GO:0006084) | 3.30283546 |
| 84 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 3.30154482 |
| 85 | cellular protein catabolic process (GO:0044257) | 3.29887771 |
| 86 | keratinocyte development (GO:0003334) | 3.28977804 |
| 87 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 3.27542670 |
| 88 | endocardial cushion development (GO:0003197) | 3.27412730 |
| 89 | regulation of vacuole organization (GO:0044088) | 3.26181264 |
| 90 | multicellular organismal water homeostasis (GO:0050891) | 3.26112938 |
| 91 | exocrine pancreas development (GO:0031017) | 3.26050478 |
| 92 | lysine catabolic process (GO:0006554) | 3.25535722 |
| 93 | lysine metabolic process (GO:0006553) | 3.25535722 |
| 94 | * detection of chemical stimulus (GO:0009593) | 3.25379119 |
| 95 | endocrine hormone secretion (GO:0060986) | 3.20201953 |
| 96 | zinc ion transport (GO:0006829) | 3.19121598 |
| 97 | proline biosynthetic process (GO:0006561) | 3.16864034 |
| 98 | norepinephrine metabolic process (GO:0042415) | 3.13851684 |
| 99 | negative regulation of microtubule polymerization (GO:0031115) | 3.12856423 |
| 100 | copper ion homeostasis (GO:0055070) | 3.12610405 |
| 101 | amyloid precursor protein catabolic process (GO:0042987) | 3.11947198 |
| 102 | interferon-gamma secretion (GO:0072643) | 3.11866129 |
| 103 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.09374508 |
| 104 | cellular response to topologically incorrect protein (GO:0035967) | 3.07694326 |
| 105 | localization within membrane (GO:0051668) | 3.06502360 |
| 106 | citrulline biosynthetic process (GO:0019240) | 3.01996978 |
| 107 | response to unfolded protein (GO:0006986) | 3.00759040 |
| 108 | lung secretory cell differentiation (GO:0061140) | 3.00652152 |
| 109 | atrioventricular valve morphogenesis (GO:0003181) | 3.00566312 |
| 110 | * detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 22.3999269 |
| 111 | response to endoplasmic reticulum stress (GO:0034976) | 2.99302991 |
| 112 | catechol-containing compound biosynthetic process (GO:0009713) | 2.99135301 |
| 113 | catecholamine biosynthetic process (GO:0042423) | 2.99135301 |
| 114 | negative regulation of kidney development (GO:0090185) | 2.97950808 |
| 115 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.97927734 |
| 116 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.97481693 |
| 117 | cellular response to interferon-alpha (GO:0035457) | 2.97468577 |
| 118 | peptidyl-asparagine modification (GO:0018196) | 2.96652206 |
| 119 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 2.95388060 |
| 120 | acyl-CoA biosynthetic process (GO:0071616) | 2.95321094 |
| 121 | thioester biosynthetic process (GO:0035384) | 2.95321094 |
| 122 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 2.94830396 |
| 123 | protein targeting to Golgi (GO:0000042) | 2.94511964 |
| 124 | glandular epithelial cell differentiation (GO:0002067) | 2.91869429 |
| 125 | negative regulation of response to reactive oxygen species (GO:1901032) | 2.91396666 |
| 126 | regulation of ruffle assembly (GO:1900027) | 2.90997272 |
| 127 | epithelial cell-cell adhesion (GO:0090136) | 2.90936848 |
| 128 | carnitine metabolic process (GO:0009437) | 2.90902559 |
| 129 | myelin maintenance (GO:0043217) | 2.90405003 |
| 130 | plasma membrane repair (GO:0001778) | 2.87119226 |
| 131 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.86455181 |
| 132 | ectoderm development (GO:0007398) | 2.84773295 |
| 133 | regulation of hippo signaling (GO:0035330) | 2.83250039 |
| 134 | carnitine shuttle (GO:0006853) | 2.82857575 |
| 135 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.82119655 |
| 136 | intestinal epithelial cell development (GO:0060576) | 2.81536111 |
| 137 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.81456799 |
| 138 | peptide biosynthetic process (GO:0043043) | 2.81243891 |
| 139 | phosphatidylinositol 3-kinase signaling (GO:0014065) | 2.79856120 |
| 140 | protein N-linked glycosylation (GO:0006487) | 2.79074607 |
| 141 | ruffle organization (GO:0031529) | 2.78930417 |
| 142 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.78655758 |
| 143 | cellular modified amino acid catabolic process (GO:0042219) | 2.78485297 |
| 144 | fatty acid elongation (GO:0030497) | 2.78179900 |
| 145 | response to topologically incorrect protein (GO:0035966) | 2.78120888 |
| 146 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.77525875 |
| 147 | copper ion transport (GO:0006825) | 2.72372594 |
| 148 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.70615317 |
| 149 | positive regulation of regulated secretory pathway (GO:1903307) | 2.69574313 |
| 150 | aspartate family amino acid catabolic process (GO:0009068) | 2.65417205 |
| 151 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.65155615 |
| 152 | endoplasmic reticulum organization (GO:0007029) | 2.65130580 |
| 153 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 2.63465809 |
| 154 | coenzyme catabolic process (GO:0009109) | 2.62048584 |
| 155 | ER overload response (GO:0006983) | 2.61561649 |
| 156 | regulation of cellular extravasation (GO:0002691) | 2.59281923 |
| 157 | establishment of protein localization to Golgi (GO:0072600) | 2.55813665 |
| 158 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.54763637 |
| 159 | peroxisome fission (GO:0016559) | 2.51583617 |
| 160 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.50515613 |
| 161 | fatty acid oxidation (GO:0019395) | 2.47903421 |
| 162 | pattern specification involved in kidney development (GO:0061004) | 2.46409038 |
| 163 | cellular response to hydrogen peroxide (GO:0070301) | 2.45444323 |
| 164 | protein localization to Golgi apparatus (GO:0034067) | 2.45023414 |
| 165 | biotin metabolic process (GO:0006768) | 2.44660441 |
| 166 | lipid oxidation (GO:0034440) | 2.42694233 |
| 167 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 2.41985901 |
| 168 | amino-acid betaine metabolic process (GO:0006577) | 2.41969700 |
| 169 | germ cell migration (GO:0008354) | 2.41713970 |
| 170 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.40422761 |
| 171 | fatty acid catabolic process (GO:0009062) | 2.39161046 |
| 172 | cardiac muscle cell proliferation (GO:0060038) | 2.38359353 |
| 173 | secretion by tissue (GO:0032941) | 2.36061954 |
| 174 | lung cell differentiation (GO:0060479) | 2.32420438 |
| 175 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.32225868 |
| 176 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.31064601 |
| 177 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.29164106 |
| 178 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.28040815 |
| 179 | L-phenylalanine catabolic process (GO:0006559) | 2.28040815 |
| 180 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.27873567 |
| 181 | sulfur amino acid catabolic process (GO:0000098) | 2.27670698 |
| 182 | urinary tract smooth muscle contraction (GO:0014848) | 13.5755814 |
| 183 | peristalsis (GO:0030432) | 12.3444129 |
| 184 | * detection of chemical stimulus involved in sensory perception of taste (GO:0050912) | 12.1815966 |
| 185 | * detection of chemical stimulus involved in sensory perception (GO:0050907) | 10.4854433 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 4.08692498 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.67119652 |
| 3 | * ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.15817385 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.03284869 |
| 5 | * ELF5_23300383_ChIP-Seq_T47D_Human | 2.91368089 |
| 6 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.77886458 |
| 7 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.77012309 |
| 8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.56615154 |
| 9 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.51808856 |
| 10 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.49739615 |
| 11 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.46288436 |
| 12 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 2.37246520 |
| 13 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.36733551 |
| 14 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.28723436 |
| 15 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.25361048 |
| 16 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.19141771 |
| 17 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 2.05474516 |
| 18 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.01244604 |
| 19 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.96114925 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.92958756 |
| 21 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.87046648 |
| 22 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.80919516 |
| 23 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.80435643 |
| 24 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.79285132 |
| 25 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.72891950 |
| 26 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.71902439 |
| 27 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.71536800 |
| 28 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.67801446 |
| 29 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.67453284 |
| 30 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.66147463 |
| 31 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.65568422 |
| 32 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.64185729 |
| 33 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.62322712 |
| 34 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.60885393 |
| 35 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.60525955 |
| 36 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.60479731 |
| 37 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.58924046 |
| 38 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.58911296 |
| 39 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.57865233 |
| 40 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.57741790 |
| 41 | P68_20966046_ChIP-Seq_HELA_Human | 1.56750231 |
| 42 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.54802057 |
| 43 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.53791195 |
| 44 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.51242911 |
| 45 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.50951410 |
| 46 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.50342273 |
| 47 | * AR_21909140_ChIP-Seq_LNCAP_Human | 1.49935939 |
| 48 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.49437387 |
| 49 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.49027668 |
| 50 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.46454771 |
| 51 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.46255025 |
| 52 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.45069973 |
| 53 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.44529912 |
| 54 | MYC_22102868_ChIP-Seq_BL_Human | 1.44455831 |
| 55 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.43469663 |
| 56 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.43284270 |
| 57 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.43088403 |
| 58 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.40258308 |
| 59 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.39253630 |
| 60 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.39171912 |
| 61 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.37204995 |
| 62 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.34541692 |
| 63 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.34407660 |
| 64 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.34155922 |
| 65 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.32909021 |
| 66 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.31126221 |
| 67 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.31086274 |
| 68 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.31045857 |
| 69 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.30764131 |
| 70 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.30478558 |
| 71 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.29538345 |
| 72 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.29046321 |
| 73 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.27198226 |
| 74 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.26457506 |
| 75 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.25385997 |
| 76 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.25385997 |
| 77 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.23917972 |
| 78 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.23201451 |
| 79 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.22397674 |
| 80 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.22287906 |
| 81 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.20815883 |
| 82 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.20343841 |
| 83 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.20160528 |
| 84 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.19837389 |
| 85 | GATA1_22025678_ChIP-Seq_K562_Human | 1.19831464 |
| 86 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.19442701 |
| 87 | KDM2B_26808549_Chip-Seq_K562_Human | 1.19291295 |
| 88 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.18038450 |
| 89 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.17549832 |
| 90 | ATF3_27146783_Chip-Seq_COLON_Human | 1.17410701 |
| 91 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.16362853 |
| 92 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.15153688 |
| 93 | RXR_22108803_ChIP-Seq_LS180_Human | 1.14962322 |
| 94 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.14625168 |
| 95 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.13689768 |
| 96 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.13295674 |
| 97 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.11730889 |
| 98 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 1.11544623 |
| 99 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.10794654 |
| 100 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.10421241 |
| 101 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.10217789 |
| 102 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.09738805 |
| 103 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.09707141 |
| 104 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.09661277 |
| 105 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.09270797 |
| 106 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.08677574 |
| 107 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.08672447 |
| 108 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.07828657 |
| 109 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.06900960 |
| 110 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.06875269 |
| 111 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.06313708 |
| 112 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.05624976 |
| 113 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.04787866 |
| 114 | KDM2B_26808549_Chip-Seq_REH_Human | 1.04408085 |
| 115 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.04155648 |
| 116 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.04023494 |
| 117 | FLI1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.01973255 |
| 118 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.01522851 |
| 119 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.01146914 |
| 120 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.00796752 |
| 121 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.00198569 |
| 122 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.99993474 |
| 123 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.99533488 |
| 124 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.99031488 |
| 125 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.98109261 |
| 126 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.97693802 |
| 127 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.97585259 |
| 128 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.97441535 |
| 129 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.97191710 |
| 130 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95940220 |
| 131 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.94699599 |
| 132 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.94126801 |
| 133 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.93971920 |
| 134 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.93328738 |
| 135 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.93302903 |
| 136 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.92947052 |
| 137 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.92672003 |
| 138 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.92442765 |
| 139 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.92031023 |
| 140 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.91832314 |
| 141 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.91701584 |
| 142 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.91144263 |
| 143 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.91031226 |
| 144 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.90921910 |
| 145 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.90440171 |
| 146 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.90115909 |
| 147 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.89666386 |
| 148 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.89089143 |
| 149 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.88931773 |
| 150 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87997736 |
| 151 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.87842478 |
| 152 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.87842478 |
| 153 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.85635654 |
| 154 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.85119075 |
| 155 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.83761542 |
| 156 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.83761542 |
| 157 | GATA3_21867929_ChIP-Seq_TH1_Mouse | 0.83426543 |
| 158 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.83125522 |
| 159 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.82564639 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001346_abnormal_lacrimal_gland | 7.67839979 |
| 2 | MP0010030_abnormal_orbit_morphology | 5.45866442 |
| 3 | MP0005248_abnormal_Harderian_gland | 3.92352500 |
| 4 | MP0005083_abnormal_biliary_tract | 3.90602106 |
| 5 | MP0009780_abnormal_chondrocyte_physiolo | 3.49456054 |
| 6 | MP0002009_preneoplasia | 3.43657145 |
| 7 | MP0003045_fibrosis | 3.38017905 |
| 8 | MP0000613_abnormal_salivary_gland | 3.33250019 |
| 9 | MP0005220_abnormal_exocrine_pancreas | 3.19480563 |
| 10 | MP0010234_abnormal_vibrissa_follicle | 2.92646100 |
| 11 | MP0005501_abnormal_skin_physiology | 2.82716155 |
| 12 | MP0001881_abnormal_mammary_gland | 2.67924211 |
| 13 | MP0005623_abnormal_meninges_morphology | 2.63985963 |
| 14 | MP0002896_abnormal_bone_mineralization | 2.59048684 |
| 15 | MP0004264_abnormal_extraembryonic_tissu | 2.57937754 |
| 16 | MP0001666_abnormal_nutrient_absorption | 2.29911909 |
| 17 | MP0009764_decreased_sensitivity_to | 2.27755714 |
| 18 | MP0003183_abnormal_peptide_metabolism | 2.24608075 |
| 19 | MP0004381_abnormal_hair_follicle | 2.24393490 |
| 20 | MP0005646_abnormal_pituitary_gland | 2.23732393 |
| 21 | MP0005332_abnormal_amino_acid | 2.23377940 |
| 22 | MP0005365_abnormal_bile_salt | 2.21631701 |
| 23 | MP0005085_abnormal_gallbladder_physiolo | 2.11138666 |
| 24 | MP0002254_reproductive_system_inflammat | 2.06929912 |
| 25 | MP0004019_abnormal_vitamin_homeostasis | 2.04466176 |
| 26 | MP0000537_abnormal_urethra_morphology | 2.02545810 |
| 27 | MP0000377_abnormal_hair_follicle | 2.01623955 |
| 28 | MP0003690_abnormal_glial_cell | 1.93213821 |
| 29 | MP0000427_abnormal_hair_cycle | 1.84735161 |
| 30 | MP0003806_abnormal_nucleotide_metabolis | 1.66267120 |
| 31 | MP0002168_other_aberrant_phenotype | 1.56432953 |
| 32 | MP0001533_abnormal_skeleton_physiology | 1.55927731 |
| 33 | MP0001873_stomach_inflammation | 1.55215913 |
| 34 | MP0000566_synostosis | 1.54583867 |
| 35 | MP0001216_abnormal_epidermal_layer | 1.54167632 |
| 36 | MP0000579_abnormal_nail_morphology | 1.53380168 |
| 37 | MP0000747_muscle_weakness | 1.48439971 |
| 38 | MP0009384_cardiac_valve_regurgitation | 1.39295992 |
| 39 | MP0004130_abnormal_muscle_cell | 1.38007975 |
| 40 | MP0004510_myositis | 1.36719261 |
| 41 | MP0003878_abnormal_ear_physiology | 1.36612840 |
| 42 | MP0005377_hearing/vestibular/ear_phenot | 1.36612840 |
| 43 | MP0000858_altered_metastatic_potential | 1.32971873 |
| 44 | MP0004233_abnormal_muscle_weight | 1.31681782 |
| 45 | MP0005379_endocrine/exocrine_gland_phen | 1.31302580 |
| 46 | MP0000383_abnormal_hair_follicle | 1.31144112 |
| 47 | MP0009765_abnormal_xenobiotic_induced | 1.26305083 |
| 48 | MP0003633_abnormal_nervous_system | 1.24844941 |
| 49 | MP0005360_urolithiasis | 1.23655204 |
| 50 | MP0008875_abnormal_xenobiotic_pharmacok | 1.23573952 |
| 51 | MP0003866_abnormal_defecation | 1.23103579 |
| 52 | MP0001299_abnormal_eye_distance/ | 1.18886177 |
| 53 | MP0003566_abnormal_cell_adhesion | 1.17851731 |
| 54 | MP0004272_abnormal_basement_membrane | 1.16716934 |
| 55 | MP0002139_abnormal_hepatobiliary_system | 1.14878644 |
| 56 | MP0003936_abnormal_reproductive_system | 1.12191036 |
| 57 | MP0001664_abnormal_digestion | 1.10904351 |
| 58 | MP0010329_abnormal_lipoprotein_level | 1.09950008 |
| 59 | MP0002166_altered_tumor_susceptibility | 1.08276751 |
| 60 | MP0010771_integument_phenotype | 1.07372414 |
| 61 | MP0003632_abnormal_nervous_system | 1.06867287 |
| 62 | MP0003300_gastrointestinal_ulcer | 1.06840780 |
| 63 | MP0005197_abnormal_uvea_morphology | 1.05931700 |
| 64 | MP0002118_abnormal_lipid_homeostasis | 1.05224125 |
| 65 | MP0003631_nervous_system_phenotype | 1.04394549 |
| 66 | MP0005075_abnormal_melanosome_morpholog | 1.04381675 |
| 67 | MP0000490_abnormal_crypts_of | 1.04040547 |
| 68 | MP0008789_abnormal_olfactory_epithelium | 1.02764195 |
| 69 | MP0005058_abnormal_lysosome_morphology | 1.02562320 |
| 70 | MP0001944_abnormal_pancreas_morphology | 1.02091485 |
| 71 | MP0003315_abnormal_perineum_morphology | 1.00129328 |
| 72 | MP0000647_abnormal_sebaceous_gland | 1.00082916 |
| 73 | MP0002796_impaired_skin_barrier | 0.98650742 |
| 74 | MP0009931_abnormal_skin_appearance | 0.98351404 |
| 75 | MP0005275_abnormal_skin_tensile | 0.95414460 |
| 76 | MP0001727_abnormal_embryo_implantation | 0.94020572 |
| 77 | MP0002115_abnormal_skeleton_extremities | 0.92459718 |
| 78 | MP0000627_abnormal_mammary_gland | 0.92320103 |
| 79 | MP0005167_abnormal_blood-brain_barrier | 0.91894360 |
| 80 | MP0010386_abnormal_urinary_bladder | 0.89608266 |
| 81 | MP0005319_abnormal_enzyme/_coenzyme | 0.88823192 |
| 82 | MP0003329_amyloid_beta_deposits | 0.88179382 |
| 83 | MP0009643_abnormal_urine_homeostasis | 0.87453288 |
| 84 | MP0004270_analgesia | 0.87145240 |
| 85 | MP0001919_abnormal_reproductive_system | 0.86997123 |
| 86 | MP0003705_abnormal_hypodermis_morpholog | 0.86990228 |
| 87 | MP0002282_abnormal_trachea_morphology | 0.85247300 |
| 88 | MP0003724_increased_susceptibility_to | 0.83159839 |
| 89 | MP0005187_abnormal_penis_morphology | 0.81642701 |
| 90 | MP0004185_abnormal_adipocyte_glucose | 0.81300865 |
| 91 | MP0005395_other_phenotype | 0.80380305 |
| 92 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.80067320 |
| 93 | MP0002098_abnormal_vibrissa_morphology | 0.79123001 |
| 94 | MP0003075_altered_response_to | 0.79121358 |
| 95 | MP0005636_abnormal_mineral_homeostasis | 0.77736491 |
| 96 | MP0004782_abnormal_surfactant_physiolog | 0.77136476 |
| 97 | MP0000920_abnormal_myelination | 0.76524678 |
| 98 | MP0004859_abnormal_synaptic_plasticity | 0.76431395 |
| 99 | MP0004145_abnormal_muscle_electrophysio | 0.75458560 |
| 100 | MP0000609_abnormal_liver_physiology | 0.75093615 |
| 101 | MP0008770_decreased_survivor_rate | 0.75076686 |
| 102 | MP0000470_abnormal_stomach_morphology | 0.74593998 |
| 103 | MP0002277_abnormal_respiratory_mucosa | 0.74366393 |
| 104 | MP0000367_abnormal_coat/_hair | 0.73409143 |
| 105 | MP0000762_abnormal_tongue_morphology | 0.73272246 |
| 106 | MP0002006_tumorigenesis | 0.72121738 |
| 107 | MP0005390_skeleton_phenotype | 0.72014490 |
| 108 | MP0008438_abnormal_cutaneous_collagen | 0.71535373 |
| 109 | MP0010678_abnormal_skin_adnexa | 0.70611901 |
| 110 | MP0003453_abnormal_keratinocyte_physiol | 0.70474650 |
| 111 | MP0000681_abnormal_thyroid_gland | 0.70028254 |
| 112 | MP0000163_abnormal_cartilage_morphology | 0.69844804 |
| 113 | MP0003795_abnormal_bone_structure | 0.69624376 |
| 114 | MP0005310_abnormal_salivary_gland | 0.69142678 |
| 115 | MP0003191_abnormal_cellular_cholesterol | 0.68651072 |
| 116 | MP0001765_abnormal_ion_homeostasis | 0.68197551 |
| 117 | MP0004858_abnormal_nervous_system | 0.67890807 |
| 118 | MP0001243_abnormal_dermal_layer | 0.65791200 |
| 119 | MP0003123_paternal_imprinting | 0.62148550 |
| 120 | MP0003763_abnormal_thymus_physiology | 0.61735950 |
| 121 | MP0001348_abnormal_lacrimal_gland | 0.59421280 |
| 122 | MP0005381_digestive/alimentary_phenotyp | 0.56874726 |
| 123 | MP0002078_abnormal_glucose_homeostasis | 0.56514288 |
| 124 | MP0002060_abnormal_skin_morphology | 0.56512064 |
| 125 | MP0001663_abnormal_digestive_system | 0.56323705 |
| 126 | MP0005666_abnormal_adipose_tissue | 0.56227146 |
| 127 | MP0003656_abnormal_erythrocyte_physiolo | 0.55993953 |
| 128 | MP0002136_abnormal_kidney_physiology | 0.55828706 |
| 129 | MP0002332_abnormal_exercise_endurance | 0.55560418 |
| 130 | MP0003879_abnormal_hair_cell | 0.55450814 |
| 131 | MP0005408_hypopigmentation | 0.54450566 |
| 132 | MP0001849_ear_inflammation | 0.54092653 |
| 133 | MP0002113_abnormal_skeleton_development | 0.54073555 |
| 134 | MP0000604_amyloidosis | 0.53418597 |
| 135 | MP0002909_abnormal_adrenal_gland | 0.53313114 |
| 136 | MP0005375_adipose_tissue_phenotype | 0.53000147 |
| 137 | MP0010630_abnormal_cardiac_muscle | 0.52726765 |
| 138 | MP0003303_peritoneal_inflammation | 0.52441884 |
| 139 | MP0000598_abnormal_liver_morphology | 0.52023314 |
| 140 | MP0000467_abnormal_esophagus_morphology | 0.51828915 |
| 141 | MP0001756_abnormal_urination | 0.49705524 |
| 142 | MP0010155_abnormal_intestine_physiology | 0.45275983 |
| 143 | MP0003938_abnormal_ear_development | 0.42755373 |
| 144 | MP0002933_joint_inflammation | 0.41165719 |
| 145 | MP0002653_abnormal_ependyma_morphology | 0.41066550 |
| 146 | MP0001544_abnormal_cardiovascular_syste | 0.40890697 |
| 147 | MP0005385_cardiovascular_system_phenoty | 0.40890697 |
| 148 | MP0002751_abnormal_autonomic_nervous | 0.39703376 |
| 149 | MP0009672_abnormal_birth_weight | 0.39612293 |
| 150 | MP0000678_abnormal_parathyroid_gland | 0.39609519 |
| 151 | MP0005409_darkened_coat_color | 0.37983965 |
| 152 | MP0002088_abnormal_embryonic_growth/wei | 0.37696908 |
| 153 | MP0003941_abnormal_skin_development | 0.35033195 |
| 154 | MP0003693_abnormal_embryo_hatching | 0.34473849 |
| 155 | MP0003699_abnormal_female_reproductive | 0.32869710 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pili torti (HP:0003777) | 9.13122844 |
| 2 | Curly hair (HP:0002212) | 7.43374139 |
| 3 | Tinnitus (HP:0000360) | 6.56621442 |
| 4 | Fibular aplasia (HP:0002990) | 6.36393002 |
| 5 | Abnormal hair laboratory examination (HP:0003328) | 5.80301026 |
| 6 | Mesomelia (HP:0003027) | 5.14967454 |
| 7 | Short 1st metacarpal (HP:0010034) | 5.04377958 |
| 8 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 5.04377958 |
| 9 | Sensorimotor neuropathy (HP:0007141) | 4.84200861 |
| 10 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 4.78680906 |
| 11 | Thin bony cortex (HP:0002753) | 4.74382760 |
| 12 | Septate vagina (HP:0001153) | 4.64921996 |
| 13 | Cortical dysplasia (HP:0002539) | 4.63500874 |
| 14 | Congenital ichthyosiform erythroderma (HP:0007431) | 4.60280603 |
| 15 | Sparse lateral eyebrow (HP:0005338) | 4.56765349 |
| 16 | Humeroradial synostosis (HP:0003041) | 4.53167890 |
| 17 | Synostosis involving the elbow (HP:0003938) | 4.53167890 |
| 18 | Abnormality of the 1st metacarpal (HP:0010009) | 4.39456495 |
| 19 | Enlarged epiphyses (HP:0010580) | 4.38331463 |
| 20 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 4.21807237 |
| 21 | Spastic diplegia (HP:0001264) | 4.17721238 |
| 22 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 3.88827755 |
| 23 | Distal lower limb muscle weakness (HP:0009053) | 3.83227701 |
| 24 | Abnormal pupillary function (HP:0007686) | 3.81463061 |
| 25 | Gout (HP:0001997) | 3.79883649 |
| 26 | Tongue fasciculations (HP:0001308) | 3.71334371 |
| 27 | Microretrognathia (HP:0000308) | 3.67406612 |
| 28 | Abnormality of the 2nd finger (HP:0004100) | 3.54002327 |
| 29 | Akinesia (HP:0002304) | 3.53758048 |
| 30 | Radial bowing (HP:0002986) | 3.51018330 |
| 31 | Exostoses (HP:0100777) | 3.46233743 |
| 32 | Deformed tarsal bones (HP:0008119) | 3.45310481 |
| 33 | Tubulointerstitial nephritis (HP:0001970) | 3.43642052 |
| 34 | Flat capital femoral epiphysis (HP:0003370) | 3.42995569 |
| 35 | Flattened epiphyses (HP:0003071) | 3.37508805 |
| 36 | Concave nail (HP:0001598) | 3.34627305 |
| 37 | Muscle fibrillation (HP:0010546) | 3.21595637 |
| 38 | Gonadotropin excess (HP:0000837) | 3.17855988 |
| 39 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 3.14285462 |
| 40 | Abnormality of the middle phalanges of the toes (HP:0010183) | 3.13678578 |
| 41 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 3.11356687 |
| 42 | Severe Myopia (HP:0011003) | 3.07126532 |
| 43 | Right ventricular cardiomyopathy (HP:0011663) | 3.07055518 |
| 44 | 2-3 toe syndactyly (HP:0004691) | 3.06664985 |
| 45 | Fibular hypoplasia (HP:0003038) | 3.03846624 |
| 46 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 3.02870211 |
| 47 | Myopathic facies (HP:0002058) | 3.02189697 |
| 48 | Hypoparathyroidism (HP:0000829) | 3.01326585 |
| 49 | Hydroxyprolinuria (HP:0003080) | 2.99105104 |
| 50 | Abnormality of proline metabolism (HP:0010907) | 2.99105104 |
| 51 | Breast carcinoma (HP:0003002) | 2.98436960 |
| 52 | Short phalanx of the thumb (HP:0009660) | 2.97456779 |
| 53 | Increased CSF protein (HP:0002922) | 2.94290168 |
| 54 | Asymmetry of the thorax (HP:0001555) | 2.85847700 |
| 55 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 2.85042721 |
| 56 | Bowed forearm bones (HP:0003956) | 2.84835173 |
| 57 | Bowing of the arm (HP:0006488) | 2.84835173 |
| 58 | Adactyly (HP:0009776) | 2.84694332 |
| 59 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.84021722 |
| 60 | Hypoplastic ischia (HP:0003175) | 2.83974790 |
| 61 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 2.82978541 |
| 62 | Renal salt wasting (HP:0000127) | 2.81768873 |
| 63 | Short tibia (HP:0005736) | 2.76311431 |
| 64 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.73346515 |
| 65 | Germ cell neoplasia (HP:0100728) | 2.71922714 |
| 66 | Hyporeflexia of lower limbs (HP:0002600) | 2.71504305 |
| 67 | Abnormality of the intrinsic pathway (HP:0010989) | 2.71355201 |
| 68 | Anosmia (HP:0000458) | 2.70046004 |
| 69 | Hamartoma of the eye (HP:0010568) | 2.68105994 |
| 70 | Flat acetabular roof (HP:0003180) | 2.68104181 |
| 71 | Conjunctival hamartoma (HP:0100780) | 2.67748543 |
| 72 | Diminished movement (HP:0002374) | 2.65625560 |
| 73 | Ankle clonus (HP:0011448) | 2.63703470 |
| 74 | Short hallux (HP:0010109) | 2.63212596 |
| 75 | Lymphangioma (HP:0100764) | 2.62792035 |
| 76 | Enlarged penis (HP:0000040) | 2.60618283 |
| 77 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 2.59931392 |
| 78 | Hypoplasia of the pons (HP:0012110) | 2.59520831 |
| 79 | Narrow nasal bridge (HP:0000446) | 2.59237636 |
| 80 | Ankyloglossia (HP:0010296) | 2.58692482 |
| 81 | Diaphragmatic weakness (HP:0009113) | 2.58202571 |
| 82 | Subcapsular cataract (HP:0000523) | 2.56417068 |
| 83 | Abnormal tarsal ossification (HP:0008369) | 2.55516929 |
| 84 | Abnormality of the ischium (HP:0003174) | 2.54032985 |
| 85 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.53931292 |
| 86 | Abnormality of nail color (HP:0100643) | 2.53363443 |
| 87 | Abnormality of the common coagulation pathway (HP:0010990) | 2.52493520 |
| 88 | Short metatarsal (HP:0010743) | 2.52072727 |
| 89 | Vascular calcification (HP:0004934) | 2.51008495 |
| 90 | Ulnar claw (HP:0001178) | 2.50930538 |
| 91 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 2.48947430 |
| 92 | Mucopolysacchariduria (HP:0008155) | 2.45807418 |
| 93 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.45807418 |
| 94 | Oligomenorrhea (HP:0000876) | 2.44794548 |
| 95 | Ketosis (HP:0001946) | 2.43206148 |
| 96 | Deep venous thrombosis (HP:0002625) | 2.42986192 |
| 97 | Premature skin wrinkling (HP:0100678) | 2.42071389 |
| 98 | Testicular neoplasm (HP:0010788) | 2.42028893 |
| 99 | Testicular atrophy (HP:0000029) | 2.41910920 |
| 100 | Back pain (HP:0003418) | 2.41704536 |
| 101 | Cardiovascular calcification (HP:0011915) | 2.41556318 |
| 102 | Dysostosis multiplex (HP:0000943) | 2.40720863 |
| 103 | Fasciculations (HP:0002380) | 2.37663286 |
| 104 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 2.37564857 |
| 105 | Conjugated hyperbilirubinemia (HP:0002908) | 2.35233085 |
| 106 | Bulbar palsy (HP:0001283) | 2.34257728 |
| 107 | Epiphyseal stippling (HP:0010655) | 2.34073338 |
| 108 | Amelogenesis imperfecta (HP:0000705) | 2.33693093 |
| 109 | Lip pit (HP:0100267) | 2.31665746 |
| 110 | Partial duplication of the phalanx of hand (HP:0009999) | 2.31177027 |
| 111 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.29214297 |
| 112 | Clumsiness (HP:0002312) | 2.29125450 |
| 113 | Malnutrition (HP:0004395) | 2.27114586 |
| 114 | Infantile muscular hypotonia (HP:0008947) | 2.24808877 |
| 115 | Abnormality of the pons (HP:0007361) | 2.22468110 |
| 116 | Macroorchidism (HP:0000053) | 2.22143471 |
| 117 | Aplasia/Hypoplasia of metatarsal bones (HP:0001964) | 2.21810900 |
| 118 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.21778682 |
| 119 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.21778682 |
| 120 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.21778682 |
| 121 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 2.21040364 |
| 122 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.20712274 |
| 123 | Severe short stature (HP:0003510) | 2.19081782 |
| 124 | Hypokinesia (HP:0002375) | 2.18687942 |
| 125 | Partial duplication of thumb phalanx (HP:0009944) | 2.15906959 |
| 126 | Short humerus (HP:0005792) | 2.15442161 |
| 127 | Congenital glaucoma (HP:0001087) | 2.15332961 |
| 128 | Limb-girdle muscle atrophy (HP:0003797) | 2.14793582 |
| 129 | Fragile skin (HP:0001030) | 2.12697577 |
| 130 | Generalized hypopigmentation of hair (HP:0011358) | 2.12163709 |
| 131 | Type I transferrin isoform profile (HP:0003642) | 2.09783869 |
| 132 | Woolly hair (HP:0002224) | 2.09518272 |
| 133 | Osteoarthritis (HP:0002758) | 2.08712252 |
| 134 | Rectal prolapse (HP:0002035) | 2.08467495 |
| 135 | Adenoma sebaceum (HP:0009720) | 2.07411027 |
| 136 | Angiofibromas (HP:0010615) | 2.07411027 |
| 137 | Blepharitis (HP:0000498) | 2.04272644 |
| 138 | Hyperglycinuria (HP:0003108) | 2.04012128 |
| 139 | Ketoacidosis (HP:0001993) | 2.03953382 |
| 140 | Micronodular cirrhosis (HP:0001413) | 2.03728654 |
| 141 | Deep philtrum (HP:0002002) | 2.02994020 |
| 142 | Protuberant abdomen (HP:0001538) | 2.01105612 |
| 143 | Hyperglycinemia (HP:0002154) | 2.00618077 |
| 144 | Abdominal distention (HP:0003270) | 1.99679231 |
| 145 | Stridor (HP:0010307) | 1.99503170 |
| 146 | Bell-shaped thorax (HP:0001591) | 1.99438461 |
| 147 | Femoral bowing (HP:0002980) | 1.98193431 |
| 148 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.95841442 |
| 149 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.93725482 |
| 150 | Camptodactyly of toe (HP:0001836) | 1.93109828 |
| 151 | Abnormal epiphyseal ossification (HP:0010656) | 1.92573902 |
| 152 | Biliary tract neoplasm (HP:0100574) | 1.92524420 |
| 153 | Hand muscle atrophy (HP:0009130) | 1.91838334 |
| 154 | Abnormality of oral frenula (HP:0000190) | 1.90366396 |
| 155 | Blue sclerae (HP:0000592) | 1.90219302 |
| 156 | Wide cranial sutures (HP:0010537) | 1.87168044 |
| 157 | Hypoplasia of the iris (HP:0007676) | 1.87156270 |
| 158 | Visceral angiomatosis (HP:0100761) | 1.86750701 |
| 159 | Advanced eruption of teeth (HP:0006288) | 1.86621881 |
| 160 | Abnormality of glycine metabolism (HP:0010895) | 1.86068126 |
| 161 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.86068126 |
| 162 | Pulmonary artery stenosis (HP:0004415) | 1.85596966 |
| 163 | Rimmed vacuoles (HP:0003805) | 1.85198278 |
| 164 | Cardiomegaly (HP:0001640) | 1.84120108 |
| 165 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.83238175 |
| 166 | Atrophic scars (HP:0001075) | 1.79225958 |
| 167 | Brushfield spots (HP:0001088) | 1.79043732 |
| 168 | Polar cataract (HP:0010696) | 1.79010249 |
| 169 | Bone cyst (HP:0012062) | 1.78623960 |
| 170 | Cervical subluxation (HP:0003308) | 1.77850892 |
| 171 | Renal tubular acidosis (HP:0001947) | 1.75527971 |
| 172 | Rhizomelia (HP:0008905) | 1.74989460 |
| 173 | Subacute progressive viral hepatitis (HP:0006572) | 1.73559545 |
| 174 | Cerebral inclusion bodies (HP:0100314) | 1.72240961 |
| 175 | Buphthalmos (HP:0000557) | 1.70069126 |
| 176 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 1.68288358 |
| 177 | Calf muscle hypertrophy (HP:0008981) | 1.63995853 |
| 178 | Turricephaly (HP:0000262) | 1.62688405 |
| 179 | Visual hallucinations (HP:0002367) | 1.62137434 |
| 180 | Hypoplasia of dental enamel (HP:0006297) | 1.61584902 |
| 181 | Axonal loss (HP:0003447) | 1.58161121 |
| 182 | Hyperphosphatemia (HP:0002905) | 1.56990028 |
| 183 | Urethral obstruction (HP:0000796) | 1.56529027 |
| 184 | Broad hallux (HP:0010055) | 1.56048495 |
| 185 | Abolished electroretinogram (ERG) (HP:0000550) | 1.54000010 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.91855425 |
| 2 | EPHA2 | 5.73746697 |
| 3 | LATS1 | 3.92398625 |
| 4 | TESK2 | 3.83484542 |
| 5 | ERN1 | 3.50353817 |
| 6 | STK39 | 3.32074758 |
| 7 | VRK2 | 3.13155292 |
| 8 | PDK3 | 2.98893629 |
| 9 | PDK4 | 2.98893629 |
| 10 | TESK1 | 2.95283596 |
| 11 | IRAK3 | 2.90471050 |
| 12 | GRK5 | 2.87848541 |
| 13 | FER | 2.85505369 |
| 14 | MST4 | 2.37838245 |
| 15 | TNK2 | 2.29914545 |
| 16 | WNK4 | 2.23995882 |
| 17 | EEF2K | 2.13444986 |
| 18 | EIF2AK1 | 2.04810349 |
| 19 | MAP2K4 | 2.02743122 |
| 20 | TAOK3 | 1.99623273 |
| 21 | PIK3CA | 1.96520776 |
| 22 | MAP3K9 | 1.86372250 |
| 23 | TRIB3 | 1.82714215 |
| 24 | MAP3K4 | 1.79669017 |
| 25 | PDK2 | 1.77846871 |
| 26 | EPHB1 | 1.76844751 |
| 27 | ILK | 1.75156003 |
| 28 | PKN2 | 1.56110958 |
| 29 | SMG1 | 1.55671167 |
| 30 | FRK | 1.53827967 |
| 31 | NME2 | 1.49685463 |
| 32 | MAP3K2 | 1.48567256 |
| 33 | PTK6 | 1.41876293 |
| 34 | EPHA3 | 1.31404920 |
| 35 | ZAP70 | 1.30914703 |
| 36 | RET | 1.30433643 |
| 37 | PRKCI | 1.26052412 |
| 38 | LIMK1 | 1.24129339 |
| 39 | ICK | 1.20762404 |
| 40 | HIPK2 | 1.20220427 |
| 41 | MST1R | 1.16579423 |
| 42 | NEK6 | 1.15042122 |
| 43 | MAP3K7 | 1.07826444 |
| 44 | MAP2K6 | 1.06333061 |
| 45 | CDK8 | 1.06254478 |
| 46 | MAP2K7 | 1.05281675 |
| 47 | WEE1 | 1.03393501 |
| 48 | MET | 1.02965315 |
| 49 | RPS6KB2 | 1.00526317 |
| 50 | NTRK1 | 0.99554946 |
| 51 | RIPK1 | 0.96773456 |
| 52 | LATS2 | 0.94237255 |
| 53 | WNK1 | 0.93637774 |
| 54 | CDK7 | 0.88715300 |
| 55 | BMX | 0.87553627 |
| 56 | MAP3K13 | 0.86418978 |
| 57 | MAPK15 | 0.84262330 |
| 58 | PAK4 | 0.83268315 |
| 59 | CAMKK1 | 0.83081455 |
| 60 | STK38 | 0.82342859 |
| 61 | INSRR | 0.81548690 |
| 62 | UHMK1 | 0.76989370 |
| 63 | LRRK2 | 0.75739794 |
| 64 | EIF2AK3 | 0.75697712 |
| 65 | NTRK3 | 0.75439561 |
| 66 | STK24 | 0.74543231 |
| 67 | SIK1 | 0.71824793 |
| 68 | DDR2 | 0.71544047 |
| 69 | MAP2K2 | 0.70713011 |
| 70 | PAK3 | 0.69730705 |
| 71 | IRAK1 | 0.69247310 |
| 72 | MAPKAPK5 | 0.64537173 |
| 73 | PDGFRA | 0.64213739 |
| 74 | TSSK6 | 0.63819004 |
| 75 | SCYL2 | 0.63090504 |
| 76 | PTK2 | 0.61253456 |
| 77 | STK3 | 0.60005276 |
| 78 | KSR2 | 0.59068868 |
| 79 | TRIM28 | 0.57510575 |
| 80 | IRAK2 | 0.57152278 |
| 81 | FGFR4 | 0.55800416 |
| 82 | TBK1 | 0.55660447 |
| 83 | PDGFRB | 0.53304843 |
| 84 | IRAK4 | 0.51054686 |
| 85 | NUAK1 | 0.50924415 |
| 86 | MAP2K3 | 0.50477006 |
| 87 | DMPK | 0.49346307 |
| 88 | JAK2 | 0.48593728 |
| 89 | CAMK1D | 0.48112448 |
| 90 | PRKD1 | 0.47666022 |
| 91 | CDK5 | 0.47361447 |
| 92 | CAMK1G | 0.47056651 |
| 93 | AURKB | 0.46548288 |
| 94 | MAP3K12 | 0.45976869 |
| 95 | PDPK1 | 0.45968649 |
| 96 | TAOK1 | 0.45772423 |
| 97 | TRPM7 | 0.45239785 |
| 98 | ERBB2 | 0.45022100 |
| 99 | OXSR1 | 0.44201817 |
| 100 | GRK6 | 0.44024073 |
| 101 | TTN | 0.43555698 |
| 102 | DAPK2 | 0.42250704 |
| 103 | MAPK12 | 0.42170734 |
| 104 | PDK1 | 0.41822008 |
| 105 | MAPKAPK2 | 0.41760557 |
| 106 | ALK | 0.40880613 |
| 107 | MTOR | 0.40563507 |
| 108 | FGFR2 | 0.40449833 |
| 109 | TGFBR2 | 0.40308878 |
| 110 | MAP3K3 | 0.38675540 |
| 111 | FLT3 | 0.38362831 |
| 112 | TAF1 | 0.38124398 |
| 113 | JAK1 | 0.37950513 |
| 114 | PAK2 | 0.37894722 |
| 115 | CDK12 | 0.37428423 |
| 116 | RPS6KA2 | 0.37112120 |
| 117 | MAPKAPK3 | 0.35961729 |
| 118 | FGFR3 | 0.35646729 |
| 119 | CAMK2G | 0.34638607 |
| 120 | CAMK2B | 0.34583933 |
| 121 | RPS6KB1 | 0.33778437 |
| 122 | MINK1 | 0.32003030 |
| 123 | LMTK2 | 0.31658922 |
| 124 | CSNK1E | 0.31536617 |
| 125 | FYN | 0.31456343 |
| 126 | FGR | 0.31077248 |
| 127 | PAK6 | 0.31059271 |
| 128 | ARAF | 0.30576538 |
| 129 | BCR | 0.30506378 |
| 130 | CDK6 | 0.29902250 |
| 131 | MATK | 0.28879415 |
| 132 | MAP3K11 | 0.27367081 |
| 133 | VRK1 | 0.26139266 |
| 134 | MAP2K1 | 0.25068485 |
| 135 | SRC | 0.23576842 |
| 136 | AKT2 | 0.23368059 |
| 137 | TYRO3 | 0.22504639 |
| 138 | EPHA4 | 0.22428753 |
| 139 | CAMK2D | 0.21807598 |
| 140 | MAP3K1 | 0.20915868 |
| 141 | CSNK1A1 | 0.20350759 |
| 142 | INSR | 0.19379195 |
| 143 | MAP4K1 | 0.17999339 |
| 144 | MARK2 | 0.17062612 |
| 145 | TLK1 | 0.15926510 |
| 146 | PRKCD | 0.14689730 |
| 147 | MAP3K14 | 0.13526067 |
| 148 | MAPK11 | 0.13144725 |
| 149 | BMPR2 | 0.12868243 |
| 150 | ROCK2 | 0.11042902 |
| 151 | PRKD2 | 0.10913614 |
| 152 | CAMK1 | 0.10575940 |
| 153 | MAPK8 | 0.10004862 |
| 154 | YES1 | 0.09076082 |
| 155 | STK10 | 0.08577926 |
| 156 | MYLK | 0.08389986 |
| 157 | CDC42BPA | 0.08236573 |
| 158 | MAP3K8 | 0.07579980 |
| 159 | DAPK1 | 0.07507694 |
| 160 | GSK3B | 0.05745962 |
| 161 | CSNK1D | 0.05331780 |
| 162 | PIK3CG | 0.04445120 |
| 163 | MAPK10 | 0.03997294 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 6.01662631 |
| 2 | Protein export_Homo sapiens_hsa03060 | 4.48903864 |
| 3 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 4.10680342 |
| 4 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 4.10084609 |
| 5 | Tyrosine metabolism_Homo sapiens_hsa00350 | 4.03774829 |
| 6 | Salivary secretion_Homo sapiens_hsa04970 | 4.00591639 |
| 7 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.33452091 |
| 8 | Other glycan degradation_Homo sapiens_hsa00511 | 3.03530596 |
| 9 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.79471312 |
| 10 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.74685956 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.62031904 |
| 12 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.28964609 |
| 13 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.26098571 |
| 14 | Taste transduction_Homo sapiens_hsa04742 | 2.21014002 |
| 15 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.10653410 |
| 16 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.05611715 |
| 17 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.03350178 |
| 18 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.01319856 |
| 19 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.99107307 |
| 20 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.85275562 |
| 21 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.83356573 |
| 22 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.80513676 |
| 23 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.76922621 |
| 24 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.51786128 |
| 25 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.51595814 |
| 26 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.47706853 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.45723559 |
| 28 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.42577564 |
| 29 | Peroxisome_Homo sapiens_hsa04146 | 1.37203994 |
| 30 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.36590104 |
| 31 | Sulfur relay system_Homo sapiens_hsa04122 | 1.33264627 |
| 32 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.30705568 |
| 33 | Histidine metabolism_Homo sapiens_hsa00340 | 1.24549526 |
| 34 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.19705925 |
| 35 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.15393534 |
| 36 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.15138322 |
| 37 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.14054793 |
| 38 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.07489737 |
| 39 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.06795686 |
| 40 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.04621568 |
| 41 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.02334279 |
| 42 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.02270534 |
| 43 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.01732112 |
| 44 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.01160572 |
| 45 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.94855500 |
| 46 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.94426517 |
| 47 | Bile secretion_Homo sapiens_hsa04976 | 0.93893003 |
| 48 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.93678160 |
| 49 | Thyroid cancer_Homo sapiens_hsa05216 | 0.80033322 |
| 50 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.79208114 |
| 51 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.78497280 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.78024336 |
| 53 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.76339463 |
| 54 | Carbon metabolism_Homo sapiens_hsa01200 | 0.76017146 |
| 55 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.74166927 |
| 56 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.72778089 |
| 57 | Insulin resistance_Homo sapiens_hsa04931 | 0.69118379 |
| 58 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.68206875 |
| 59 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.67878042 |
| 60 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.66916167 |
| 61 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.66867841 |
| 62 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.66413298 |
| 63 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.66282576 |
| 64 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.64919961 |
| 65 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.64517483 |
| 66 | Insulin secretion_Homo sapiens_hsa04911 | 0.63986679 |
| 67 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.62878149 |
| 68 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.62585221 |
| 69 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.60124114 |
| 70 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.59865267 |
| 71 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.58067676 |
| 72 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.57490857 |
| 73 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.57186799 |
| 74 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56791427 |
| 75 | Long-term potentiation_Homo sapiens_hsa04720 | 0.56751265 |
| 76 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.56453874 |
| 77 | Endometrial cancer_Homo sapiens_hsa05213 | 0.55676259 |
| 78 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.52519679 |
| 79 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.51827154 |
| 80 | Lysine degradation_Homo sapiens_hsa00310 | 0.51581839 |
| 81 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.50943400 |
| 82 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.48832986 |
| 83 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.46503154 |
| 84 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.45931412 |
| 85 | Olfactory transduction_Homo sapiens_hsa04740 | 0.44611293 |
| 86 | Bladder cancer_Homo sapiens_hsa05219 | 0.44439714 |
| 87 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.44130917 |
| 88 | Renin secretion_Homo sapiens_hsa04924 | 0.43383639 |
| 89 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.43383308 |
| 90 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.43162339 |
| 91 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.42073382 |
| 92 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.41842742 |
| 93 | GABAergic synapse_Homo sapiens_hsa04727 | 0.41484191 |
| 94 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.41252138 |
| 95 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.40088320 |
| 96 | Endocytosis_Homo sapiens_hsa04144 | 0.39710890 |
| 97 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.39263012 |
| 98 | Lysosome_Homo sapiens_hsa04142 | 0.38882253 |
| 99 | Prostate cancer_Homo sapiens_hsa05215 | 0.38669256 |
| 100 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.38086575 |
| 101 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.37625256 |
| 102 | Hepatitis C_Homo sapiens_hsa05160 | 0.37521768 |
| 103 | Tight junction_Homo sapiens_hsa04530 | 0.37322439 |
| 104 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.37267517 |
| 105 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.36933169 |
| 106 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.36556433 |
| 107 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.36445002 |
| 108 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.35968144 |
| 109 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.35871800 |
| 110 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.35227900 |
| 111 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.34992290 |
| 112 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.34570662 |
| 113 | Cocaine addiction_Homo sapiens_hsa05030 | 0.34136112 |
| 114 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.33903892 |
| 115 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.33546378 |
| 116 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.33242287 |
| 117 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.31508713 |
| 118 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.30520818 |
| 119 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.30319961 |
| 120 | Galactose metabolism_Homo sapiens_hsa00052 | 0.28755894 |
| 121 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.28221097 |
| 122 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.27565067 |
| 123 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.26393171 |
| 124 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.25934699 |
| 125 | Circadian entrainment_Homo sapiens_hsa04713 | 0.25873487 |
| 126 | Pertussis_Homo sapiens_hsa05133 | 0.25107187 |
| 127 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.25037341 |
| 128 | ABC transporters_Homo sapiens_hsa02010 | 0.24779422 |
| 129 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.24220669 |
| 130 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.24103073 |
| 131 | Amoebiasis_Homo sapiens_hsa05146 | 0.24037913 |
| 132 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.24020040 |
| 133 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.23332537 |
| 134 | Metabolic pathways_Homo sapiens_hsa01100 | 0.22688870 |
| 135 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.22439181 |
| 136 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.22319953 |
| 137 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.20438629 |
| 138 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.18245266 |
| 139 | Melanogenesis_Homo sapiens_hsa04916 | 0.18175515 |
| 140 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.14231480 |
| 141 | Base excision repair_Homo sapiens_hsa03410 | 0.13861931 |
| 142 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.13189119 |
| 143 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.12620480 |
| 144 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.12594066 |
| 145 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.12286950 |
| 146 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.12024470 |
| 147 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.11525136 |
| 148 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.09376712 |
| 149 | Hepatitis B_Homo sapiens_hsa05161 | 0.05195641 |

